To develop Ap-NP complex capable of specifically targeting GBM cells, Gu and colleagues designed composite NPs (CNPs) modified with the DNA aptamer SL1, which specifically targets c-Met, highly expressed on GBM cells. This evidence concerns the gene MET and glioblastoma.